The Spanish Association of Orphan and Ultra Orphan Drug Laboratories (AELMHU) has announced the appointment of Beatriz Perales as the new president of the Association. The new Board of Directors will also include María José Sánchez, general manager in Spain and Portugal at CSL Behring, as vice president; José Luis Moreno, general manager in Italy, Spain and Portugal at Ultragenyx, as secretary; Sergio Bullón, general manager in Spain at Alnylam Pharmaceuticals, who continues as treasurer; and Iván Silva, director of Market Access for the Southern cluster and managing director of Spain at Kyowa Kirin, who joins the Board for the first time as a member.

The new Board of Directors was elected at the Ordinary Assembly, held at Takeda's offices.

Access the full press release here.